Choose Your News
Loading...
Tags:
Thumbnail
An amended collaboration agreement limited the types of immune cells that will be pursued by the duo, but that could create more value for Editas... [Read More]
The FDA approves Roche (RHHBY) unit Genentech's Tecentriq (atezolizumab), combined with chemo [Celgene's Abraxane (paclitaxel protein-bound; nab-paclitaxel... [Read More]
Thumbnail
Four cheap energy stocks for investors to consider, on the expectation that the increasingly unpopular sector will emerge from a decadelong slump. Plus: a bet... [Read More]
Preview